Global Metagenomic Sequencing Market Overview:
Global Metagenomic Sequencing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Metagenomic Sequencing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Metagenomic Sequencing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Metagenomic Sequencing Market:
The Metagenomic Sequencing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Metagenomic Sequencing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Metagenomic Sequencing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Metagenomic Sequencing market has been segmented into:
Reagents & Consumables
Instruments
Services
Analysis & Data Interpretation Solutions
By Application, Metagenomic Sequencing market has been segmented into:
16S rRNA
Shotgun
Metatranscriptomics
Whole-Genome Sequencing & De Novo Assembly
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Metagenomic Sequencing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Metagenomic Sequencing market.
Top Key Players Covered in Metagenomic Sequencing market are:
BGI Group
DNAStar Inc.
Eurofins Scientific
GENEWIZ
Illumina Inc.
IntegraGen SA
Macrogen Inc.
Microsynth AG
Novogene Corporation
NuGEN Technologies Inc.
Oxford Nanopore Technologies Ltd.
PerkinElmer
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Zymo Research Corporation
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Metagenomic Sequencing Market Type
4.1 Metagenomic Sequencing Market Snapshot and Growth Engine
4.2 Metagenomic Sequencing Market Overview
4.3 Reagents & Consumables
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Reagents & Consumables: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Instruments: Geographic Segmentation Analysis
4.5 Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Services: Geographic Segmentation Analysis
4.6 Analysis & Data Interpretation Solutions
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Analysis & Data Interpretation Solutions: Geographic Segmentation Analysis
Chapter 5: Metagenomic Sequencing Market Application
5.1 Metagenomic Sequencing Market Snapshot and Growth Engine
5.2 Metagenomic Sequencing Market Overview
5.3 16S rRNA
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 16S rRNA: Geographic Segmentation Analysis
5.4 Shotgun
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Shotgun: Geographic Segmentation Analysis
5.5 Metatranscriptomics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Metatranscriptomics: Geographic Segmentation Analysis
5.6 Whole-Genome Sequencing & De Novo Assembly
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Whole-Genome Sequencing & De Novo Assembly: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Metagenomic Sequencing Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BGI GROUP; DNASTAR
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; EUROFINS SCIENTIFIC; GENEWIZ; ILLUMINA
6.4 INC.; INTEGRAGEN SA; MACROGEN
6.5 INC.; MICROSYNTH AG; NOVOGENE CORPORATION; NUGEN TECHNOLOGIES
6.6 INC.; OXFORD NANOPORE TECHNOLOGIES LTD.; PERKINELMER; QIAGEN N.V.; THERMO FISHER SCIENTIFIC
6.7 INC.; ZYMO RESEARCH CORPORATION
Chapter 7: Global Metagenomic Sequencing Market By Region
7.1 Overview
7.2. North America Metagenomic Sequencing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Reagents & Consumables
7.2.2.2 Instruments
7.2.2.3 Services
7.2.2.4 Analysis & Data Interpretation Solutions
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 16S rRNA
7.2.3.2 Shotgun
7.2.3.3 Metatranscriptomics
7.2.3.4 Whole-Genome Sequencing & De Novo Assembly
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Metagenomic Sequencing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Reagents & Consumables
7.3.2.2 Instruments
7.3.2.3 Services
7.3.2.4 Analysis & Data Interpretation Solutions
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 16S rRNA
7.3.3.2 Shotgun
7.3.3.3 Metatranscriptomics
7.3.3.4 Whole-Genome Sequencing & De Novo Assembly
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Metagenomic Sequencing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Reagents & Consumables
7.4.2.2 Instruments
7.4.2.3 Services
7.4.2.4 Analysis & Data Interpretation Solutions
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 16S rRNA
7.4.3.2 Shotgun
7.4.3.3 Metatranscriptomics
7.4.3.4 Whole-Genome Sequencing & De Novo Assembly
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Metagenomic Sequencing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Reagents & Consumables
7.5.2.2 Instruments
7.5.2.3 Services
7.5.2.4 Analysis & Data Interpretation Solutions
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 16S rRNA
7.5.3.2 Shotgun
7.5.3.3 Metatranscriptomics
7.5.3.4 Whole-Genome Sequencing & De Novo Assembly
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Metagenomic Sequencing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Reagents & Consumables
7.6.2.2 Instruments
7.6.2.3 Services
7.6.2.4 Analysis & Data Interpretation Solutions
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 16S rRNA
7.6.3.2 Shotgun
7.6.3.3 Metatranscriptomics
7.6.3.4 Whole-Genome Sequencing & De Novo Assembly
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Metagenomic Sequencing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Reagents & Consumables
7.7.2.2 Instruments
7.7.2.3 Services
7.7.2.4 Analysis & Data Interpretation Solutions
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 16S rRNA
7.7.3.2 Shotgun
7.7.3.3 Metatranscriptomics
7.7.3.4 Whole-Genome Sequencing & De Novo Assembly
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Metagenomic Sequencing Scope:
|
Report Data
|
Metagenomic Sequencing Market
|
|
Metagenomic Sequencing Market Size in 2025
|
USD XX million
|
|
Metagenomic Sequencing CAGR 2025 - 2032
|
XX%
|
|
Metagenomic Sequencing Base Year
|
2024
|
|
Metagenomic Sequencing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
BGI Group, DNAStar Inc., Eurofins Scientific, GENEWIZ, Illumina Inc., IntegraGen SA, Macrogen Inc., Microsynth AG, Novogene Corporation, NuGEN Technologies Inc., Oxford Nanopore Technologies Ltd., PerkinElmer, QIAGEN N.V., Thermo Fisher Scientific Inc., Zymo Research Corporation.
|
|
Key Segments
|
By Type
Reagents & Consumables
Instruments
Services
Analysis & Data Interpretation Solutions
By Applications
16S rRNA
Shotgun
Metatranscriptomics
Whole-Genome Sequencing & De Novo Assembly
|
